Smart Peptide Hydrogels That Release Wound-Healing Signals When They Detect Injury Enzymes

The researchers synthesized three hybrid peptides and characterized them using circular dichroism, thioflavin T assay, transmission electron microscopy, atomic force microscopy, scanning electron cryomicroscopy, and rheological testing. They tested stability in water and plasma, and enzyme susceptibility. Cytotoxicity was assessed on fibroblasts and keratinocytes using XTT and LDH assays. Wound healing was evaluated in a mouse dorsal skin injury model with histological analysis.

Wound healing peptides like GHK are effective but break down quickly, requiring repeated application. This hydrogel system solves that problem by acting as both a protective scaffold for new skin cells and a controlled-release reservoir that only delivers healing peptides when wound-related enzymes are present. This enzyme-triggered release is an elegant design — the gel responds to the wound environment itself.

Self-assembling peptide hydrogels represent a growing area of regenerative medicine. The innovation here is the enzyme-responsive release mechanism — the material doesn't just passively release peptides over time, it specifically responds to wound-related enzymes. This approach could be applied beyond wound healing to deliver anti-inflammatory or antimicrobial peptides in other tissue engineering applications where enzyme-triggered drug release would be beneficial.

Wound healing was only demonstrated in a mouse model, and mouse skin heals differently from human skin. The abstract doesn't report specific wound closure rates, healing times, or quantitative comparisons. Only two of the three hybrid peptides (RADA-GHK and RADA-KGHK) were tested in the wound model — RADA-RDKVYR results aren't mentioned for in vivo. Long-term biocompatibility and manufacturing scalability are unknown.